Eric Deflesselle
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Depression, antidepressant use, and breast cancer incidence: results from the E3N prospective cohort.
Journal: Psychiatry and clinical neurosciences
Published: December 13, 2024
Unlike other medical conditions, type 2 diabetes is a risk factor for new-onset major depression after COVID-19.
Journal: Journal of psychosomatic research
Published: March 21, 2024
Habenular volume changes after venlafaxine treatment in patients with major depression.
Journal: Psychiatry and clinical neurosciences
Published: December 11, 2023
Socio-spatial inequalities in presence of primary care physicians and patients' ability to register: A simulated-patient survey in the Paris Region.
Journal: Public health
Published: November 29, 2023
Habenular volume in depressed patients.
Journal: Psychiatry and clinical neurosciences
Published: August 31, 2022
Burnout, anxiety, insomnia and depressive symptoms among French outpatient physicians in the second wave of COVID-19: Comparison between general practitioners and specialists
Journal: L'Encephale
Published: June 07, 2022
The ERICH3 rs11580409 polymorphism is associated with 6-month antidepressant response in depressed patients.
Journal: Progress in neuro-psychopharmacology & biological psychiatry
Published: April 21, 2022
Psychological distress among outpatient physicians in private practice linked to COVID-19 and related mental health during the second lockdown.
Journal: Journal of psychiatric research
Published: August 30, 2021
The olfactory deficits of depressed patients are restored after remission with venlafaxine treatment.
Journal: Psychological medicine
Published: October 22, 2020
Lower plasma vascular endothelial growth factor A in major depressive disorder not normalized after antidepressant treatment: A case control study.
Journal: The Australian and New Zealand journal of psychiatry
Published: December 12, 2019
Human Dermal Fibroblast: A Promising Cellular Model to Study Biological Mechanisms of Major Depression and Antidepressant Drug Response.
Journal: Current neuropharmacology
Published: July 12, 2019
Last Updated: 09/26/2026